101 related articles for article (PubMed ID: 2752907)
1. Susceptibility of clinical isolates to dactimicin and gentamicin.
Bergan T
Drugs Exp Clin Res; 1989; 15(3):109-12. PubMed ID: 2752907
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial activity of dactimicin in vitro compared with that of dibekacin, netilmicin, sisomicin and micronomicin.
Inouye S; Hara T; Matsuhashi Y; Kitasato I
Drugs Exp Clin Res; 1989; 15(10):455-63. PubMed ID: 2632214
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of dactimicin and other aminoglycosides against bacteria producing aminoglycoside-modifying enzymes.
Felmingham D; Jones K
Drugs Exp Clin Res; 1989; 15(3):133-6. PubMed ID: 2752913
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
Tsai TY; Chang SC; Hsueh PR; Feng NH; Wang JT
J Microbiol Immunol Infect; 2007 Dec; 40(6):481-6. PubMed ID: 18087627
[TBL] [Abstract][Full Text] [Related]
5. Preclinical comparative evaluation of aminoglycosides.
Abbate GF; Alagia I; Giaquinto E; Giordano B; Leonessa V; Altucci P
Chemioterapia; 1984 Dec; 3(6):378-84. PubMed ID: 6529780
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial activity of dactimicin against aerobic and anaerobic bacteria isolated from intra-abdominal infections.
Nord CE; Kager L
Drugs Exp Clin Res; 1989; 15(3):113-4. PubMed ID: 2752908
[TBL] [Abstract][Full Text] [Related]
7. [Comparative in vitro activity of dibekacin, gentamicin and tobramycin on 617 bacterial strains].
Coulet M; Brun Y; Forey F; Fleurette J
Nouv Presse Med; 1982 Nov; 11(46):3391-5. PubMed ID: 7155846
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of netilmicin and cefotaxime compared to that of other aminoglycosides.
Shah PM; Belve V
Methods Find Exp Clin Pharmacol; 1979 Dec; 1(5):285-8. PubMed ID: 552591
[TBL] [Abstract][Full Text] [Related]
9. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
Bovelacci A; Montini G; Ramacciotti PG
Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413
[TBL] [Abstract][Full Text] [Related]
10. In vitro study of dactimicin (ST 900) against methicillin-susceptible and -resistant staphylococci.
Stefani S; Mezzatesta M; Oliveri S; Nicolosi VM; Russo G
Chemioterapia; 1987 Aug; 6(4):264-8. PubMed ID: 3652276
[TBL] [Abstract][Full Text] [Related]
11. In vitro bactericidal activity and post-antibiotic effect of dactimicin, a new aminoglycoside, alone and in combination with other antibiotics.
Debbia EA; Schito GC; Stefani S; Nicoletti G
Drugs Exp Clin Res; 1989; 15(3):125-8. PubMed ID: 2752911
[TBL] [Abstract][Full Text] [Related]
12. Dactimicin, a new, less toxic aminoglycoside antibiotic active against resistant bacteria.
Omoto S; Yoshida T; Kurebe M; Inouye S
Drugs Exp Clin Res; 1987; 13(12):719-25. PubMed ID: 3447874
[TBL] [Abstract][Full Text] [Related]
13. Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations.
Jones RN; Huynh HK; Biedenbach DJ; Fritsche TR; Sader HS
J Antimicrob Chemother; 2004 Jul; 54(1):144-54. PubMed ID: 15190031
[TBL] [Abstract][Full Text] [Related]
14. [Estimation of level of aminoglycosides susceptibility of bacterial strains isolated from patients with systemic and general infections].
Kowalska-Krochmal B; Dolna I; Dobosz A; Wrzyszcz E; GoĊciniak G
Med Dosw Mikrobiol; 2008; 60(3):205-14. PubMed ID: 19143174
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibility of nosocomial Pseudomonas aeruginosa, enterobacteriaceae, and staphylococci to ciprofloxacin and ten other broad-spectrum antibiotics.
Weinstein RA; Nathan C; Delzell D; Kabins SA
Chemioterapia; 1987 Oct; 6(5):315-8. PubMed ID: 3123078
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of dactimicin in the treatment of experimentally induced intra-abdominal infections.
Nord CE; Lahnborg G
Drugs Exp Clin Res; 1989; 15(3):115-8. PubMed ID: 2752909
[TBL] [Abstract][Full Text] [Related]
17. [Evolution of bacterial resistance to five aminoglycosides. A study of 3,354 strains isolated in a hospital milieu].
Fourche J; Texier-Maugein J; Mormede M
Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):665-70. PubMed ID: 3054744
[TBL] [Abstract][Full Text] [Related]
18. Minimum inhibitory concentration determinations for various antimicrobial agents against 1570 bacterial isolates from turkey poults.
Salmon SA; Watts JL
Avian Dis; 2000; 44(1):85-98. PubMed ID: 10737648
[TBL] [Abstract][Full Text] [Related]
19. The in-vitro activity of roxithromycin, a new macrolide antibiotic, in comparison with that of erythromycin.
King A; Phillips I
Drugs Exp Clin Res; 1987; 13(9):563-6. PubMed ID: 3428135
[TBL] [Abstract][Full Text] [Related]
20. First microbiological approach to dactimicin, a novel aminoglycoside antibiotic.
Stefani S; Nicoletti G; Russo G; Toscano MA
Drugs Exp Clin Res; 1987; 13(12):727-9. PubMed ID: 3447875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
